High Performance Medical Plastics Market Forecasts to 2028 – Global Analysis By Type (Polyphenylene Sulfide (PPS), Polyetherimide (PEI)), Application (Drug Delivery, Medical Equipment) and By Geography
According to Stratistics MRC, the Global High Performance Medical Plastics Market is accounted for $789.42 million in 2020 and is expected to reach $1,667.74 million by 2028 growing at a CAGR of 9.8% during the forecast period. The increasing use of high-performance medical plastics is the major factor driving the market growth. However, the time-consuming regulatory approval process is hampering market growth.
High performance plastics are particularly designed polymers with high mechanical strength, chemical resistance, and most importantly, temperature resistance.
Based on the application, the medical equipment & tools segment is going to have lucrative growth during the forecast period. This is attributed to an increase in demand for 3D printing high performance plastics in medical devices.
By geography, North America is going to have high growth during the forecast period. The medical devices market in North America is highly diversified and offers a variety of products to diagnose and treat patients, ranging from medical catheters to vascular grafts and implants.
Some of the key players profiled in the High Performance Medical Plastics Market include Arkema SA, Celanese Corporation, DuPont , Ensinger, Evonik Industries AG, Mitsubishi Chemical Corporation, Raumedic AG, Rochling SE & Co. AG, SABIC, Saint-Gobain Performance Plastics , Solvay SA, Tekni-Plex, The Chemours Company, Trelleborg, and Victrex PLC.
Estimated Market Size in 2020:
USD 789.42 million
Compound Annual Growth Rate (CAGR) from2020 to 2028:
Predicted 2028 Value:
USD 1,667.74 million
Tables, Graphs& Figures
Type, Application and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
• Polyphenylene Sulfide (PPS)
• Polyetherimide (PEI)
• Polyaryletherketone (PAEK)
• High Performance Polyamides (HPPA)
• Fluoropolymers (FP)
• Drug Delivery
• Medical Equipment & Tools
• Medical Supplies
• Prosthesis & Implants
• Therapeutic System
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global High Performance Medical Plastics Market is majorly driven by rising geriatric population, increasing use of high-performance medical plastics in advanced medical technology, and growing healthcare investments in emerging economies.
The fluropolymers (FP) segment is growing at a highest CAGR due to their extensive use in medical supplies such as catheters, vascular grafts, reusable syringes, dialyzers, and surgical instruments, among others.
North America dominated with a significant market share due to the factors such as technological advancements in design and manufacturing, existing medical device manufacturers in the region, and product modernization in terms of quality and application development.
Asia Pacific market is growing at a highest CAGR due to the increasing demand for medical devices & their associated products, and growing industrialization in emerging countries such as India and China.
Key players in High Performance Medical Plastics Market include Arkema SA, Celanese Corporation, DuPont, Ensinger, Evonik Industries AG, Mitsubishi Chemical Corporation, Raumedic AG, Rochling SE & Co. AG, SABIC, Saint-Gobain Performance Plastics, Solvay SA, Tekni-Plex, The Chemours Company, Trelleborg, and Victrex PLC.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.